Human LPCAT3 activation kit by CRISPRa
CAT#: GA106902
LPCAT3 CRISPRa kit - CRISPR gene activation of human lysophosphatidylcholine acyltransferase 3
CNY 12255.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | LPCAT3 |
Locus ID | 10162 |
Kit Components | GA106902G1, LPCAT3 gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA106902G2, LPCAT3 gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA106902G3, LPCAT3 gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Reference Data | |
RefSeq | NM_005768 |
Synonyms | C3F; LPCAT; LPLAT 5; LPSAT; MBOAT5; nessy; OACT5 |
Summary | Acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (LPCAT activity). Catalyzes also the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3-phospho-L-serine or LPS) into phosphatidylserine (1,2-diacyl-sn-glycero-3-phospho-L-serine or PS) (LPSAT activity). Has also weak lysophosphatidylethanolamine acyltransferase activity (LPEAT activity). Favors polyunsaturated fatty acyl-CoAs as acyl donors compared to saturated fatty acyl-CoAs. Seems to be the major enzyme contributing to LPCAT activity in the liver. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle.[UniProtKB/Swiss-Prot Function] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN409485 | LPCAT3 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8680.00 |